Plikaytis, Brian D.

Trends in Mortality Due to Invasive Mycotic Diseases in the United States, 1980–1997

McNeil, M. M., Nash, S. L., Hajjeh, R. A., Phelan, M. A., Conn, L. A., Plikaytis, B. D., & Warnock, D. W. (2001) · Clinical Infectious Diseases

Antifungal resistance and susceptibilityFungal Infections and Studies

Cited by 657

Excess mortality, hospital stay, and cost due to candidemia: a case-control study using data from population-based candidemia surveillance

Morgan, J., Meltzer, M. I., Plikaytis, B. D., Sofair, A. N., Huie-White, S., Wilcox, S., Harrison, L. H., Seaberg, E. C., Hajjeh, R. A., & Teutsch, S. M. (2005) · Infection Control & Hospital Epidemiology

Antifungal resistance and susceptibilityFungal Infections and Studies

Cited by 437

Risk factors for severe pulmonary and disseminated coccidioidomycosis: Kern County, California, 1995–1996

Rosenstein, N. E., Emery, K. W., Werner, S. B., Kao, A., Johnson, R., Rogers, D., Vugia, D., Reingold, A., Talbot, R., Plikaytis, B. D., et al. (2001) · Clinical Infectious Diseases

Fungal Infections and StudiesAntifungal resistance and susceptibility

Cited by 232

Evaluation of Amphotericin B Interpretive Breakpoints for Candida Bloodstream Isolates by Correlation with Therapeutic Outcome

Park, B. J., Arthington-Skaggs, B. A., Hajjeh, R. A., Iqbal, N., Ciblak, M. A., Lee-Yang, W., Hairston, M. D., Phelan, M., Plikaytis, B. D., Sofair, A. N., et al. (2006) · Antimicrobial Agents and Chemotherapy

Antifungal resistance and susceptibilityBacterial Identification and Susceptibility Testing

Cited by 113

Coccidioidomycosis in human immunodeficiency virus-infected persons in Arizona, 1994–1997: incidence, risk factors, and prevention

Woods, C. W., McRill, C., Plikaytis, B. D., Rosenstein, N. E., Mosley, D., Boyd, D., England, B., Perkins, B. A., Ampel, N. M., & Hajjeh, R. A. (2000) · The Journal of Infectious Diseases

Fungal Infections and StudiesPneumocystis jirovecii pneumonia detection and treatment

Cited by 107